Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login
Market Place

Approved Drug Products containing PREVACID NAPRAPAC 500 (COPACKAGED)-1 listed with Health Canada. Original Data : Health Canada Website

Client Email

Product

PREVACID NAPRAPAC 500 (COPACKAGED)-1
Canada

Renejix: CDMO with expertise in small molecule oral dosage, delivery tech, and multi-modality manufacturing.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Ribobay has expertise in oligonucleotides from siRNA, Antisense Oligonucleotides, miRNAs, and aptamers & Oligonucleotides CXOs.

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

PREVACID NAPRAPAC 500 (COPACKAGED)-1

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

39 API Suppliers, 23 USDMF, 11 CEP/COS, 1 JDMF, 3 EU WC, 37 KDMF, 12 NDC API, 1 VMF, 16 Listed Suppliers, $ API Reference Price

39 API Suppliers
23 USDMF
11 CEP/COS
1 JDMF
3 EU WC
37 KDMF
12 NDC API
1 VMF
16 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

3 Drugs in Development

3 Drugs in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

API Reference Price
API Exports
API Imports
FDF Exports
FDF Imports

INTERMEDIATES

4 API Suppliers

4 API Suppliers

FINISHED DOSAGE FORMULATIONS

327 FDF Dossiers, 115 FDA Orange Book, 96 Europe, 26 Canada, 23 Australia, 25 South Africa, 42 Listed Dossiers

327 FDF Dossiers
115 FDA Orange Book
96 Europe
26 Canada
23 Australia
25 South Africa
42 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 250MG, TABLET;ORAL - 375MG, TABLET;ORAL - 500MG, SUSPENSION;ORAL - 25MG/ML, TABLET, DELAYED RELEASE;ORAL - 375MG, TABLET, DELAYED RELEASE;ORAL - 500MG, TABLET, DELAYED RELEASE;ORAL - EQ 20MG BASE;375MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, DELAYED RELEASE;ORAL - EQ 20MG BASE;500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 250MG
TABLET;ORAL - 375MG
TABLET;ORAL - 500MG
SUSPENSION;ORAL - 25MG/ML
TABLET, DELAYED RELEASE;ORAL - 375MG
TABLET, DELAYED RELEASE;ORAL - 500MG
TABLET, DELAYED RELEASE;ORAL - EQ 20MG BASE;375MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, DELAYED RELEASE;ORAL - EQ 20MG BASE;500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 Evonik, 1 Rochem International Inc, 6 SPI Pharma, 2 Seqens, 4 DKSH, 2 Jai Radhe Sales, 11 Boai NKY Pharmaceuticals Ltd, 14 Gangwal Healthcare, 6 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 ACG Worldwide, 8 Actylis, 2 Aeon Procare, 2 Alcedo Pharmachem, 10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 33 BASF, 1 Clariant, 14 Corel Pharma Chem, 6 DFE Pharma, 3 Doshion Polyscience, 2 Finar, 12 Gangwal Chemicals, 13 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 32 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 12 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 3 Novo Excipients, 4 Pharmatrans-Sanaq, 6 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 27 Roquette, 14 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 12 Sigachi Industries, 2 The Dow Chemical Company, 4 Ulanqab Kema New Material, 2 Valens Pharmachem, 4 Vasa Pharmachem, 1 Vertellus, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

76 Fillers, Diluents & Binders, 70 Coating Systems & Additives, 41 Controlled & Modified Release, 41 Disintegrants & Superdisintegrants, 40 Direct Compression, 33 Solubilizers, 30 Thickeners and Stabilizers, 27 Granulation, 23 Film Formers & Plasticizers, 22 Co-Processed Excipients, 20 Taste Masking, 18 Lubricants & Glidants, 17 Parenteral, 16 Topical, 11 Chewable & Orodispersible Aids, 8 Emulsifying Agents, 6 API Stability Enhancers, 5 Rheology Modifiers, 5 Empty Capsules, 5 Surfactant & Foaming Agents, 5 Coloring Agents, 4 Vegetarian Capsules, 1 Soft Gelatin

76 Fillers, Diluents & Binders
70 Coating Systems & Additives
41 Controlled & Modified Release
41 Disintegrants & Superdisintegrants
40 Direct Compression
33 Solubilizers
30 Thickeners and Stabilizers
27 Granulation
23 Film Formers & Plasticizers
22 Co-Processed Excipients
20 Taste Masking
18 Lubricants & Glidants
17 Parenteral
16 Topical
11 Chewable & Orodispersible Aids
8 Emulsifying Agents
6 API Stability Enhancers
5 Rheology Modifiers
5 Empty Capsules
5 Surfactant & Foaming Agents
5 Coloring Agents
4 Vegetarian Capsules
1 Soft Gelatin

DIGITAL CONTENT

3 DATA COMPILATION #PharmaFlow, 35 NEWS #PharmaBuzz

3 DATA COMPILATION #PharmaFlow
35 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 83 Finished Drug Prices, 1 Annual Reports

1 US Medicaid Prescriptions
83 Finished Drug Prices
1 Annual Reports

MARKET PLACE

30 APIs, 3 FDF Dossiers

30 APIs
3 FDF Dossiers

REF. STANDARDS & IMPURITIES

3 EDQM, 5 USP, 14 Others

3 EDQM
5 USP
14 Others

ANALYTICAL

3 BioAnalytical Methods

3 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 37 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

26 All

01 2Orion Corporation

02 6APOTEX INC

03 3ATNAHS PHARMA UK LIMITED

04 1MEDEXUS PHARMACEUTICALS INC.

05 2MYLAN PHARMACEUTICALS ULC

06 1PRO DOC LIMITEE

07 3Pharmascience Inc.

08 6TEVA CANADA LIMITED

09 2XEDITON PHARMACEUTICALS INC

filter Active Ingredients Reset all filters

26 All

01 21NAPROXEN

02 5Naproxen

filter Dosage Form Reset all filters

26 All

01 2ORAL SUSPENSION

02 1SUPPOSITORY

03 1SUSPENSION

04 6TABLET

05 11TABLET (ENTERIC-COATED)

06 1TABLET (EXTENDED-RELEASE)

07 4TABLET (IMMEDIATE AND DELAYED-RELEASE)

filter Brand Name Reset all filters

26 All

01 3APO-NAPROXEN

02 2APO-NAPROXEN EC

03 1APO-NAPROXEN EC TABLETS

04 2MYLAN-NAPROXEN/ESOMEPRAZOLE MR

05 3NAPROSYN

06 1PEDIAPHARM NAPROXEN SUSPENSION

07 1PMS-NAPROXEN

08 2PMS-NAPROXEN EC

09 1PRO-NAPROXEN EC

10 3TEVA-NAPROXEN

11 3TEVA-NAPROXEN EC

12 2VIMOVO

13 2Blank

FDF Dossiers
FDA Orange Book
Europe
Canada
Australia
South Africa
Listed Dossiers

List of Suppliers

Product Main Page

01

Orion Corporation

AAPS 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Contact Supplier

Contact Supplier

Digital Content

Regulatory Info : Generic

Registration Country : Canada

Brand Name :

Dosage Form : ORAL SUSPENSION

Dosage Strength : 100ML

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : Canada

Fermion Orion Company Banner

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Orion Corporation

AAPS 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Contact Supplier

Contact Supplier

Digital Content

Regulatory Info : Generic

Registration Country : Canada

Brand Name :

Dosage Form : ORAL SUSPENSION

Dosage Strength : 200ML

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : Canada

Fermion Orion Company Banner

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

ATNAHS PHARMA UK LIMITED

AAPS 2024

Not Confirmed

ATNAHS PHARMA UK LIMITED

AAPS 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

Brand Name : NAPROSYN

Dosage Form : TABLET (EXTENDED-RELEASE)

Dosage Strength : 750MG

Packaging : 100

Approval Date :

Application Number : 2162466

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

ATNAHS PHARMA UK LIMITED

AAPS 2024

Not Confirmed

ATNAHS PHARMA UK LIMITED

AAPS 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

Brand Name : NAPROSYN

Dosage Form : TABLET (ENTERIC-COATED)

Dosage Strength : 500MG

Packaging : 100/500

Approval Date :

Application Number : 2162423

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

ATNAHS PHARMA UK LIMITED

AAPS 2024

Not Confirmed

ATNAHS PHARMA UK LIMITED

AAPS 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

Brand Name : NAPROSYN

Dosage Form : TABLET (ENTERIC-COATED)

Dosage Strength : 375MG

Packaging : 500

Approval Date :

Application Number : 2162415

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

Pharmascience Inc.

AAPS 2024

Not Confirmed

Pharmascience Inc.

AAPS 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

Brand Name : PMS-NAPROXEN

Dosage Form : SUPPOSITORY

Dosage Strength : 500MG

Packaging : 42673

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

07

Pharmascience Inc.

AAPS 2024

Not Confirmed

Pharmascience Inc.

AAPS 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

Brand Name : PMS-NAPROXEN EC

Dosage Form : TABLET (ENTERIC-COATED)

Dosage Strength : 500MG

Packaging : 100

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

08

Pharmascience Inc.

AAPS 2024

Not Confirmed

Pharmascience Inc.

AAPS 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

Brand Name : PMS-NAPROXEN EC

Dosage Form : TABLET (ENTERIC-COATED)

Dosage Strength : 375MG

Packaging : 100

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

09

TEVA CANADA LIMITED

AAPS 2024

Not Confirmed

TEVA CANADA LIMITED

AAPS 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

Brand Name : TEVA-NAPROXEN

Dosage Form : TABLET

Dosage Strength : 375MG

Packaging : 100/500

Approval Date :

Application Number : 627097

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

10

MEDEXUS PHARMACEUTICALS INC.

Country

AAPS 2024

Not Confirmed

MEDEXUS PHARMACEUTICALS INC.

Country

AAPS 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Country

Virtual Booth

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

Brand Name : PEDIAPHARM NAPROXEN SUSPENSION

Dosage Form : SUSPENSION

Dosage Strength : 25MG/ML

Packaging : 474ML

Approval Date :

Application Number : 2162431

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

1
2
3

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?